Status:
UNKNOWN
Investigating the Association Between Microbiota and Esophageal/Oropharyngeal Cancer
Lead Sponsor:
National Cheng-Kung University Hospital
Conditions:
Microbial Colonization
Esophageal Cancer
Eligibility:
All Genders
20-99 years
Phase:
NA
Brief Summary
Background: Esophageal cancer commonly occurs in middle-aged man. It is ranked to the 6th common cancer and 5th cancer-related death in Taiwanese male, and sometimes co-exist with oropharyngeal cancer...
Detailed Description
Esophageal cancer is one of the most common gastrointestinal malignant diseases worldwide with an estimated 456,000 incident cases annually. Esophageal cancer has a poor prognosis and high mortality r...
Eligibility Criteria
Inclusion
- Eligible participants included patients aged ≥ 20 years with oropharyngeal cancer, esophageal cancer, or dyspeptic patients without cancer.
Exclusion
- Patients with other cancer than esophageal cancer or oropharyngeal cancer.
- Patients with bleeding tendency, such as platelet \< 50k, PTinr \> 2, or using anti-coagulants.
- Patients with use of antibiotics within the past 2 weeks
Key Trial Info
Start Date :
March 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 14 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05412628
Start Date
March 15 2022
End Date
February 14 2024
Last Update
June 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cheng-Kung University Hospital
Tainan, Other (Non U.s.), Taiwan, 704